【文献速递】新知27 新冠药物可别瞎送 临床前研究少不了~KINETIN为例~
Souza, T.M.L., Pinho, V.D., Setim, C.F. et al. Preclinical development of kinetin as a safe error-prone SARS-CoV-2 antiviral able to attenuate virus-induced inflammation. Nat Commun 14, 199 (2023). https://doi.org/10.1038/s41467-023-35928-z